NoCamels
Israel’s 10 ‘Hottest’ Startups In 2019, According to WIRED Magazine
August 21, 2019
Reuters
Nobio gets FDA approval for anti-bacterial dental fillings
August 5, 2019
CTech
Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax
July 17, 2019
Cision PR Newswire
First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial
July 8, 2019
Radiology Business
AI triage solution for brain bleeds gains FDA clearance
June 17, 2019
CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
June 12, 2019
FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device
May 28, 2019
Ayala Pharmaceuticals Raises $30 Million
May 25, 2019
Israel’s Zebra Medical gets FDA ok for AI chest X-ray product
May 13, 2019
Computational Pathology Pioneer Ibex Raises $11M
March 26, 2019
Globes
Israeli migraine device co Theranica raises $35m
March 18, 2019
businesswire
Ayala Pharmaceuticals to Present Preclinical Data at AACR for AL101, a Pan-Notch Inhibitor Being Evaluated for Adenoid Cystic Carcinoma
March 6, 2019
TechCrunch
A healthcare investment fund has become one of Israel’s largest with a $660 million close
Israeli health fund aMoon II raises $660 million
The Times of Israel
Israeli firm creates particles to kill germs on contact, fight bacterial disease
August 2, 2018
Zebra Medical Vision gets $30M Series C to create AI-based tools for radiologists
June 7, 2018
MobiHealthNews
Medial EarlySign’s clinical validation trial shows promise for detecting colorectal cancer
April 17, 2018
Fierce Biotech
BiondVax, NIAID kick off phase 2 universal flu vaccine study in U.S.
April 11, 2018
Ayala notches up $17M in financing to push BMS drug into phase 2
April 10, 2018
Parkinson's News Today
Pharma Two B Doses First Patients in Early-stage Parkinson’s Phase 3 Trial
February 12, 2018
Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study
January 31, 2018
Pharma Two B Ltd. Closes $30 Million Financing Round
February 27, 2017
Marius Nacht to invest $20m in Regenera
January 2, 2018
Nacht, Harel Insurance invest in personalized cancer treatment
December 7, 2017
Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments
December 6, 2017
GlobeNewswire
Mapi Pharma Ltd. Announces Closing of $10 Million Investment
August 17, 2017
MassDevice
CartiHeal raises $18.3m to support PMA trial of Agili-C implant
May 8, 2017
